Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Totarol loaded lipase-responsive liposomes for anti Gram-positive bacterium infection.

RSC advances·2026
Same author

LC-IL but Not LC-PL Circuit Regulates Comorbid Mechanical Hyperalgesia and Anxiety in Male Rats with Chronic Post-Surgical Pain.

Journal of pain research·2026
Same author

Association between prenatal methamphetamine exposure and intracranial haemorrhage in neonates and infants: nationwide cohort study.

The British journal of psychiatry : the journal of mental science·2026
Same author

Superconducting coherence boosted by outer-layer metallic screening in multilayered cuprates.

Nature communications·2026
Same author

Integrative Transcriptomics Across Etiologies Reveals Common and Disease-Specific Fibrogenic Signatures in Liver Fibrosis.

Canadian journal of gastroenterology & hepatology·2026
Same author

Peripheral immune cell profiles and tumor marker expression in high-risk HPV-infected cervical lesions: a comparative study.

Frontiers in oncology·2026

Related Experiment Video

Updated: May 13, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K

An XGBoost-Based Multicenter Model for Predicting HBV-Related Hepatocellular Carcinoma: Development and Validation.

Yong Lin1,2, Hai-Yan Zhuo1,2, Hui-Wen Song1,3

  • 1Department of Hepatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Cancer Medicine
|April 25, 2026
PubMed
Summary

A new machine learning model accurately predicts Hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) risk using key biomarkers. This advanced tool improves upon existing methods for better patient stratification and outcomes in HBV-HCC.

Keywords:
hepatitis B virushepatocellular carcinomamachine learningpredictive model

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

872
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K

Related Experiment Videos

Last Updated: May 13, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

872
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K

Area of Science:

  • Hepatology
  • Oncology
  • Machine Learning in Medicine

Background:

  • Hepatocellular carcinoma (HCC) survival rates are stage-dependent, but current prediction models struggle with accuracy for Hepatitis B virus-associated HCC (HBV-HCC).
  • Accurate risk stratification is crucial for timely intervention and improved outcomes in HBV-HCC patients.

Purpose of the Study:

  • To develop and validate an interpretable machine learning (ML) model for HBV-HCC risk stratification.
  • To integrate multidimensional biomarkers for enhanced predictive accuracy.

Main Methods:

  • A retrospective multicenter study involving 3568 participants (1872 HBV-infected, 1696 HBV-HCC).
  • Identification of five key predictors (log10DCP, log10HBVDNA, log10ALT, AFP-L3%, log10AFP) using random forest, LASSO, and XGBoost.
  • Evaluation of seven ML models using AUC, sensitivity, specificity, accuracy, and F1-score, with comparison to existing models.

Main Results:

  • The XGBoost model demonstrated high performance with AUCs of 0.985 (training), 0.978 (validation), and 0.942 (external validation).
  • XGBoost significantly outperformed previous models (GALAD, ASAP) in accuracy and individualized risk prediction.
  • Key predictors identified include log10DCP, log10HBVDNA, log10ALT, AFP-L3%, and log10AFP.

Conclusions:

  • A novel, highly accurate diagnostic model for HBV-HCC was developed using machine learning.
  • The model offers superior risk stratification compared to existing methods, facilitating clinical implementation via a web tool.